Home/Therapeutic Areas/Immunotherapy
πŸ›‘οΈ

Immunotherapy

Treatments that harness the immune system to fight disease, including checkpoint inhibitors, CAR-T therapies, and cancer vaccines.

Companies
0
Pipeline Drugs
11
Key People
5

Immunotherapy Pipeline (11 drugs)

Phase 1/2: 3Phase 2/3: 3Phase 2: 2Phase 1: 2Approved: 1
DrugCompanyIndicationPhase
CY-101CytovationAdrenocortical CarcinomaPhase 2
CY-101 + PembrolizumabCytovationColorectal CancerPhase 1/2
BNT327BioNTechMultiple Cancer TypesPhase 2/3
COVID-19 Vaccine (BNT162b2)BioNTechCOVID-19 PreventionApproved
Individualized mRNA Cancer ImmunotherapiesBioNTechVarious Solid TumorsPhase 2/3
Shared Antigen mRNA Cancer VaccinesBioNTechCancerPhase 2
Next-generation mRNA VaccinesBioNTechInfectious DiseasesPhase 1
Targeted Oncology TherapiesBioNTechCancerPhase 1/2
PD-1 InhibitorAkesoVarious CancersPhase 2/3
Bispecific AntibodyAkesoSolid TumorsPhase 1/2
Lead CAR-T ProgramArcellxHematologic MalignanciesPhase 1